Title Yimitasvir and Sofosbuvir for HCV Genotype 1 Infection
Authors Luo, Bi-Fen
Jin, Jinglan
Rao, Huiying
Ning, Qin
Hou, Jinlin
Bai, Lang
Yang, Yongfeng
Zheng, Sujun
Mao, Xiaorong
Quan, Jun
Yang, Dongliang
Zhang, Lunli
Zhao, Caiyan
Jia, Zhansheng
Zhang, Fuchun
Gong, Zuojiong
Lin, Feng
Wang, Guiqiang
Jin, Qian
Ma, Danli
Luo, Lin
Deng, Li
Xie, Hongming
Jing, Li
Zhang, Yingjun
Wei, Lai
Affiliation Peking Univ, Hepatol Inst, Peoples Hosp, Beijing, Peoples R China.
Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China.
Huazhong Univ Sci & Technol, Wuhan, Hubei, Peoples R China.
Nanfang Hosp, Guangzhou, Peoples R China.
Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China.
Second Hosp Nanjing, Nanjing, Jiangsu, Peoples R China.
Capital Med Univ, Hosp Nanjing, Beijing, Peoples R China.
Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China.
Xiangya Hosp Cent South Univ, Changsha, Hunan, Peoples R China.
Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Infect Dis, Union Hosp, Wuhan, Hubei, Peoples R China.
Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.
Hebei Med Univ, Shijiazhuang, Hebei, Peoples R China.
Tangdu Hosp, Xian, Shaanxi, Peoples R China.
Guangzhou Eighth Peoples Hosp, Guangzhou, Guangdong, Peoples R China.
Wuhan Univ, Renmin Hosp, Dept Infect Dis, Wuhan, Hubei, Peoples R China.
Hainan Gen Hosp, Haikou, Hainan, Peoples R China.
Peking Univ, Hosp 1, Beijing, Peoples R China.
Yichang HEC Changjiang Pharmaceut Co Ltd, Yichang, Peoples R China.
Sunshine Lake Pharma Co Ltd, State Key Lab Antiinfect Drug Dev, Dongguan, Peoples R China.
Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing, Peoples R China.
Issue Date 2018
Publisher HEPATOLOGY
Citation HEPATOLOGY. 2018, 68, 583A-584A.
URI http://hdl.handle.net/20.500.11897/529801
ISSN 0270-9139
Indexed SCI(E)
Appears in Collections: 人民医院
第一医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

百度学术™


0

Checked on Current Time




License: See PKU IR operational policies.